| EMA number | EMEA/H/C/005754 |
| ATC code | J07BN04 |
| Authorisation | 10 November 2022 |
| Withdrawn | 18 March 2024 |
| Revision | 4 |
VidPrevtyn Beta is indicated as a booster for active immunisation to prevent COVID-19 in adults who have previously received an mRNA or adenoviral vector COVID-19 vaccine (see sections 4.2 and 5.1 in product information document). The use of this vaccine should be in accordance with official recommendations.